See also this year's filing and all EDGAR filings for this company.
PDF Report 0001367920_2019_Concert_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001367920, Concert Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 180,149,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,919,000 |
| 3 | remainder_Assets | 3,479,000 |
| 4 | LiabilitiesCurrent | 8,749,000 |
| 5 | LiabilitiesNoncurrent | 9,120,000 |
| 6 | remainder_Liabilities | 6,938,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 23,455,323 |
| 9 | ResearchAndDevelopmentExpense | 41,911,257 |
| 10 | remainder_Expenses | 433,197 |
| 11 | remainder_Revenues | 147,311,438 |
| 12 | remainder_NetIncome | -129,765 |
| 13 | remainder_ComprehensiveNetIncome | 270,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 192,547,000 |
| 1 | Liabilities | 24,807,000 |
| 2 | Expenses | 65,799,777 |
| 3 | Revenues | 147,311,438 |
| 4 | StockholdersEquity | 167,740,000 |
| 5 | NetIncome | 81,381,896 |
| 6 | ComprehensiveNetIncome | 81,516,896 |
| 7 | BaseVar | 215,432,490 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.11 |
| 9 | EconomicCapitalRatio | 4.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
